[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351197-105":59,"doc-detail-351197-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","epidemiological-trends-of-nash-related-liver-cancer-in-young-and-middle-aged-populations-a-global-disease-burden-analysis-from-1990-to-2021","Epidemiological trends of NASH-related liver cancer in young and middle-aged populations - A global disease burden analysis from 1990 to 2021","","Recent decades show rising incidence and mortality of early-onset cancers among individuals aged 15–49, yet updated global liver-cancer data linked to NAFLD remained limited. This observational analysis quantifies trends in NASH-attributable early-onset hepatocellular carcinoma (EO-NRLC) from 1990–2021 using GBD data across 204 countries and 21 regions and SDI strata. Prevalence, mortality, YLLs, YLDs, and DALYs were age-standardized per 100,000, with UI 95%. Indicators increased from 1990 to 2021, accelerating in higher-SDI economies (notably Australia, Europe, North America) and remaining elevated in many low-SDI settings. Males consistently exceeded females, and Bayesian age-period-cohort projections suggest sustained increases through 2040.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epidemiological-trends-of-nash-related-liver-cancer-in-young-and-middle-aged-populations-a-global-disease-burden-analysis-from-1990-to-2021/351197/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epidemiological-trends-of-nash-related-liver-cancer-in-young-and-middle-aged-populations-a-global-disease-burden-analysis-from-1990-to-2021/351197.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What cancer outcome does the study focus on?","Question",{"text":112,"@type":113},"The study analyzes epidemiological trends of NASH-attributable early-onset hepatocellular carcinoma (EO-NRLC) among young and middle-aged populations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which period and data source are used for the trend analysis?",{"text":117,"@type":113},"Trends are assessed from 1990 to 2021 using the Global Burden of Disease (GBD) study data across multiple countries, regions, and SDI strata.",{"name":119,"@type":110,"acceptedAnswer":120},"How do projected trends change beyond 2021?",{"text":121,"@type":113},"Bayesian age-period-cohort projection results indicate the prevalence and burden indicators remain high and continue increasing through 2040.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351197,1790138559,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","®  \n Observational Study   \nEpidemiological trends of NASH-related liver cancer in young and middle-aged populations A global disease burden analysis from 1990 to 2021  \nHezhen Shang, MDa ,* , Binghui Chu, MDa , Xiaoxin Yu, MDa , Nan Tang, MDa , Zengyin Chen, MDa  \n\n| Abstract\u003Cbr>Recent decades have seen an increase in the incidence and mortality rates of early-onset cancers in adolescents and adults aged 15 to 49 years. The incidence and mortality rates of liver cancer caused by NAFLD have been increasing on an annual basis; however, the most recent global data on liver cancer caused by NAFLD has not been reported. A detailed analysis of trends in early-onset hepatocellular carcinoma attributable to NASH (EO-NRLC) from 1990 to 2021 was conducted using data from the global burden of disease study for 204 countries, 21 regions, and 5 sociodemographic indices (SDI) regions, with separate analysis conducted for each category. Prevalence rates, mortality rates, YLLs, YLDs, and disability-adjusted life years (DALYs) were calculated based on vital registration data, adjusted for age and reporting per 1,00,000 population, with a UI of 95% . Subsequently, we performed SDI analysis, as well as trend analysis based on age groups. In addition to this, decomposition analysis, age-period-cohort analysis, and Bayesian age-period-cohort projection and frontier analysis were also conducted. The prevalence (0 .61 [0 .49, 0.73]), mortality (0 .48 [0 .39, 0.58]), rate of DALYs (11 .50 [9 .39, 13.84]), and morbidity (0 .49 [0 .40, 0.60]) of EO-NRLCs in 2021 compared with 1990 were increasing. The analysis indicates that age-standardized indicators, encompassing prevalence, morbidity, mortality, and DALYs, have exhibited an accelerated increase in regions characterized by higher SDIs and more economically developed economies, particularly in Australia, Europe, and North America. Conversely, numerous low SDI countries and less developed economies continue to exhibit comparatively elevated age-standardized rates for these 4 indicators. It is also noteworthy that all indicators are higher for men than for women as a whole. Subsequent Bayesian age-period-cohort projection analyses suggest that the indicators will remain high and increasing through 2040. The substantial increase in the incidence, prevalence, mortality, and DALYs of EO-NRLC across multiple regions from 1990 to 2021 is projected to impose a considerable socioeconomic burden on governments and health systems in the coming years. The findings of this study may inform policymakers in developing strategies to address EO-NRLC, with particular emphasis on strengthening professional training to mitigate the burden of this complex disease. |\n| --- |\n| Abbreviations: ASDR = age-standardized death rate, ASMR = age-standardized mortality rate, ASR = age-standardized rate, DALY = disability-adjusted life year, EO-NRLC = early-onset hepatocellular carcinoma attributable to NASH, GBD = global burden of disease, HCC = hepatocellular carcinoma, NASH = nonalcoholic steatohepatitis, SDI = sociode mographic indice. |\n| Keywords: DALYs, EO-NAFLD, GBD, liver cancer, morbidity, mortality, prevalence |\n\n1. Introduction  \nConventionally, cancer has been viewed as a disease primarily affecting older adults, typically those aged 50 and above. However, emerging evidence highlights a significant rise in early-onset cancers – defined as malignancies diagnosed in individuals under 50 – across various organ systems. [1,2] This  \nThe present study was supported by the Shandong Province Medicine and Health Science and Technology Development Program Project (2018WS374). The authors have no conflicts of interest to disclose.  \nData sharing not applicable to this article as no datasets were generated or analyzed during the current study.  \nDue to the retrospective nature of the study, written informed consent was not required.  \nSupplemental Digital Content is available for this article.  \na Department of Hepatobiliary and","cbCaivBtNS5kk9S2","https://ap.wps.com/l/cbCaivBtNS5kk9S2","pdf",2829652,16,"English","# Abstract\n# Introduction\n## Early-onset cancer burden and rationale\n## Study support and disclosures\n## Study methods framework","[{\"question\":\"What cancer outcome does the study focus on?\",\"answer\":\"The study analyzes epidemiological trends of NASH-attributable early-onset hepatocellular carcinoma (EO-NRLC) among young and middle-aged populations.\"},{\"question\":\"Which period and data source are used for the trend analysis?\",\"answer\":\"Trends are assessed from 1990 to 2021 using the Global Burden of Disease (GBD) study data across multiple countries, regions, and SDI strata.\"},{\"question\":\"How do projected trends change beyond 2021?\",\"answer\":\"Bayesian age-period-cohort projection results indicate the prevalence and burden indicators remain high and continue increasing through 2040.\"}]","Epidemiological trends of NASH-related liver cancer in young and middle-aged populations - A global disease burden analysis from 1990 to 2021 | PDF",1790093032,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8d78fed8a3b518c9962d5c5f584a606.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a12cb4368de0fb54bb72be31a9b42450.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2275b0034c7b53e403cb1492a453f533.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26fdb1f0a97b3193e613cf35c923a8cb.webp",980,1306]